EventScienceAugust 27, 2026

Ai2 and Providence Swedish expand AutoDiscovery cancer research partnership

Read original source →allenai.org

AutoDiscovery surfaced a stronger immune signature in invasive lobular breast cancer in one of the most-studied breast cancer datasets, later validated across an independent patient dataset and lab analysis. Ai2 says the finding could open immunotherapy to roughly 15% of US breast cancer diagnoses each year.

People · Kelly Paulson, Bodhisattwa Prasad Majumder

How this story unfolded

2 weeks · 2 reports · 1 community post · from Sep 1

  1. Sep 1
  2. Sep 18

More stories today

Open the live feed